N. Hida

发表

Phase 1 Clinical Study of Cyclophilin B Peptide Vaccine for Patients With Lung Cancer

H. Yamana, M. Kawamoto, K. Itoh, 2002, Journal of immunotherapy.

Immunological evaluation of CTL precursor‐oriented vaccines for advanced lung cancer patients

K. Shirouzu, H. Yamana, H. Aizawa, 2003, Cancer science.

A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients

H. Yamana, Yuji Sato, S. Todo, 2004, British Journal of Cancer.

The Impact of EGFR Mutation Status and Brain Metastasis for Non-Small Cell Lung Cancer Treated with Ramucirumab plus Docetaxel

M. Mineshita, Takeo Inoue, O. Hataji, 2020, Oncology.

A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI)

H. Okamoto, T. Shimokawa, Koshiro Watanabe, 2012, Cancer Chemotherapy and Pharmacology.

Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913

Y. Hosomi, N. Nogami, T. Shinkai, 2020, Investigational New Drugs.

A combination chemotherapy of carboplatin and irinotecan with granulocyte colony-stimulating factor (G-CSF) support in elderly patients with small cell lung cancer.

H. Kunikane, K. Naoki, H. Okamoto, 2006, Lung cancer.

Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014

Y. Hosomi, M. Shibuya, K. Sakamaki, 2015, BMC Cancer.

A Woman with Synchronous Double Lung Cancers of Hilar-type Squamous Cell Carcinoma Complicated by Total Lung Atelectasis and Peripheral Adenocarcinoma

H. Okamoto, A. Yoshizu, N. Hida, 2011 .

Detection of peptide‐specific cytotoxic T‐lymphocyte precursors used for specific immunotherapy of pancreatic cancer

M. Oka, K. Itoh, T. Mine, 2002, International journal of cancer.

Relationships among bronchodilator reversibility, the fraction of exhaled nitric oxide, and the parameters of the forced oscillation technique in adult asthma treated with inhaled corticosteroids and long-acting β2 agonists combination

T. Tsuburai, M. Mineshita, Takeo Inoue, 2020, Journal of breath research.

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force

M. Kanai, Y. Okada, S. Fuke, 2022, Nature Communications.

The relationship between peak inspiratory flow and hand grip strength measurement in men with mild chronic obstructive pulmonary disease

T. Tsuburai, Y. Komase, N. Hida, 2021, BMC Pulmonary Medicine.

DOCK2 is involved in the host genetics and biology of severe COVID-19

M. Kanai, Y. Kamatani, Y. Okada, 2022, Nature.

Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients

Koji Tanaka, S. Shichijo, F. Niiya, 2002, Japanese journal of cancer research : Gann.

Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force

M. Kanai, Y. Okada, S. Fuke, 2022, BMC infectious diseases.

Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan

M. Kanai, Y. Okada, S. Fuke, 2021, medRxiv.

Two Cases of Paragonimus Westermani Infection with Pulmonary and Brain Lesions

M. Mineshita, Y. Komase, N. Hida, 2017 .

Phase I/II study of carboplatin plus weekly nab-paclitaxel in patients aged ≥75 years with squamous-cell lung cancer: TORG1322.

Y. Hosomi, T. Yamanaka, Y. Ohe, 2020, Lung cancer.

The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non‐small cell lung cancer

M. Mineshita, Takeo Inoue, O. Hataji, 2020, Thoracic cancer.

The PCR-invader method (structure-specific 5′ nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; comparison with direct sequencing

K. Soejima, K. Naoki, H. Terai, 2011, International Journal of Clinical Oncology.

Cleavage and polyadenylation specificity factor (CPSF)‐derived peptides can induce HLA‐A2‐restricted and tumor‐specific CTLs in the majority of gastrointestinal cancer patients

S. Todo, Masaaki Ito, S. Shichijo, 2002, International journal of cancer.

A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation

H. Takasu, K. Itoh, M. Harada, 2002, Cancer Immunology, Immunotherapy.

Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients

H. Yamana, Yuji Sato, S. Todo, 2002, British Journal of Cancer.

High serum immunoglobulin G4-related retrosternal fibrosclerosis.

T. Nakazato, H. Hayashi, H. Okamoto, 2012, Journal of thoracic imaging.

Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy

H. Arioka, T. Miyaji, Takuhiro Yamaguchi, 2020, BMJ Open.

Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014

Y. Hosomi, M. Shibuya, K. Sakamaki, 2015, BMC Cancer.

Dose-escalating and pharmacokinetic study of a weekly combination of paclitaxel and carboplatin for inoperable non-small cell lung cancer: JCOG 9910-DI.

H. Kunikane, K. Naoki, H. Okamoto, 2009, Japanese journal of clinical oncology.

Complicating effects of obstructive sleep apnea syndrome on the severity of adult asthma

T. Miyazawa, T. Tsuburai, M. Mineshita, 2020, The Journal of asthma : official journal of the Association for the Care of Asthma.

A feasibility study of carboplatin plus irinotecan treatment for elderly patients with extensive disease small-cell lung cancer.

M. Nishio, H. Kenmotsu, H. Murakami, 2014, Japanese journal of clinical oncology.

Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity

M. Kanai, Y. Okada, S. Fuke, 2023, Nature Genetics.

LBA63 Placebo-controlled, double-blinded phase Ⅲ study comparing dexamethasone on day 1 with dexamethasone on days 1 to 4, with combined neurokinin-1 receptor antagonist, palonosetron, and olanzapine in patients receiving cisplatin-containing highly emetogenic chemotherapy: SPARED trial

H. Arioka, T. Miyaji, C. Katada, 2021, Annals of Oncology.

Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial).

T. Miyaji, C. Katada, Y. Ohno, 2023, British journal of cancer.